Determinants of Reduced Antiplatelet Effect of Aspirin in Patients with Stable Coronary Artery Disease

por Larsen, Sanne Bøjet, Grove, Erik Lerkevang, Neergaard-Petersen, Søs, Würtz, Morten, Hvas, Anne-Mette, Kristensen, Steen Dalby
Publicado 2015

The Influence of Haemoglobin A1c Levels on Platelet Aggregation and Platelet Turnover in Patients with Coronary Artery Disease Treated with Aspirin

por Neergaard-Petersen, Søs, Hvas, Anne-Mette, Grove, Erik Lerkevang, Larsen, Sanne Bøjet, Gregersen, Søren, Kristensen, Steen Dalby
Publicado 2015

Reduced Antiplatelet Effect of Aspirin Does Not Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease

por Larsen, Sanne Bøjet, Grove, Erik Lerkevang, Neergaard‐Petersen, Søs, Würtz, Morten, Hvas, Anne‐Mette, Kristensen, Steen Dalby
Publicado 2017

Fibrin Clot Structure and Platelet Aggregation in Patients with Aspirin Treatment Failure

por Neergaard-Petersen, Søs, Ajjan, Ramzi, Hvas, Anne-Mette, Hess, Katharina, Larsen, Sanne Bøjet, Kristensen, Steen Dalby, Grove, Erik Lerkevang
Publicado 2013

Coronary artery disease-associated genetic variants and biomarkers of inflammation

por Christiansen, Morten Krogh, Larsen, Sanne Bøjet, Nyegaard, Mette, Neergaard-Petersen, Søs, Ajjan, Ramzi, Würtz, Morten, Grove, Erik Lerkevang, Hvas, Anne-Mette, Jensen, Henrik Kjærulf, Kristensen, Steen Dalby
Publicado 2017